SCHEMBL728289

SCHEMBL728289

O=c1ccc(-c2ccccc2)ccc1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.64
DBH P09172 1/20 0.64
HDAC4 P56524 3/20 0.61
HDAC2 Q92769 3/20 0.61
HDAC8 Q9BY41 3/20 0.61
KDM4E B2RXH2 3/20 0.59
MEN1 O00255 2/20 0.59
HSP90AA1 P07900 2/20 0.59
MAPT P10636 2/20 0.59
KMT2A Q03164 2/20 0.59
MAPK1 P28482 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
ALOX5 P09917 1/20 0.56
MMP3 P08254 1/20 0.52
BCL2L1 Q07817 1/20 0.52
ACMSD Q8TDX5 3/20 0.52
HNF4A P41235 2/20 0.52
DHFR P00374 1/20 0.52
MCL1 Q07820 1/20 0.52
ALDH1A1 P00352 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22170762 0.81 HSD17B1 (0.68) HDAC4HDAC2HDAC8MEN1KMT2A
Tropolone SCHEMBL42739 0.78
SCHEMBL21471512 0.78 MCL1 (0.52) MMP2DBHHDAC4HDAC2HDAC8
SCHEMBL21471507 0.76 HDAC4 (0.69) MMP2DBHHDAC4HDAC2HDAC8
Tropolone SCHEMBL9643396 0.76 DBH (0.94) MMP2DBHHDAC4HDAC2HDAC8
Tropolone SCHEMBL531387 0.76 DBH (0.94) MMP2DBHHDAC4HDAC2HDAC8
Tropolone SCHEMBL9643338 0.76 DBH (0.94) MMP2DBHHDAC4HDAC2HDAC8
Tropolone SCHEMBL5969452 0.76 DBH (0.94) MMP2DBHHDAC4HDAC2HDAC8
Tropolone SCHEMBL9644163 0.76 DBH (0.94) MMP2DBHHDAC4HDAC2HDAC8
Tropolone SCHEMBL9644286 0.76 DBH (0.94) MMP2DBHHDAC4HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024073131-A2 METHOD OF TREATING NEURODEGENERATIVE DISEASES THE BOARD OF TRUSTEES OF THE UNIVESITY OF ILLINOIS (US) 2024-04-04 WO disclosed
US-20210163393-A1 HINOKITIOL ANALOGUES, METHODS OF PREPARING AND PHARMACEUTICAL COMPOSITIONS THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2021-06-03 US disclosed
WO-2019200314-A2 HINOKITIOL ANALOGUES, METHODS OF PREPARING AND PHARMACEUTICAL COMPOSITIONS THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2019-10-17 WO disclosed
CN-101553549-B Photobase generator and photocurable resin composition ASAHI KASEI E MATERIALS CORP (JP) 2013-02-20 CN disclosed
US-8137892-B2 Photobase generator and photocurable resin composition ASAHI KASEI CHEMICALS CORPORATION (JP) 2012-03-20 US disclosed
US-20100151386-A1 PHOTOBASE GENERATOR AND PHOTOCURABLE RESIN COMPOSITION ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-06-17 US disclosed
CN-101553549-A Photobase generator and photocurable resin composition ASAHI CHEMICAL CORP (JP) 2009-10-07 CN disclosed
EP-2093269-A1 PHOTOBASE GENERATOR AND PHOTOCURABLE RESIN COMPOSITION Asahi Kasei Chemicals Corporation (JP) 2009-08-26 EP disclosed
US-5055356-A Chelate compound HITACHI, LTD. (JP) 1991-10-08 US disclosed
EP-0357219-A1 Aluminium and aluminium alloy having corrosion-resistant protective layer, and methods of making such a layer HITACHI, LTD. (JP) 1990-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163393-A1 HINOKITIOL ANALOGUES, METHODS OF PREPARING AND PHARMACEUTICAL COMPOSITIONS THEREOF CYP27A1, CYP27B1, HSD17B7 MMP2 4356/4885DBH 618/4885HDAC4 1472/4885
US-20100151386-A1 PHOTOBASE GENERATOR AND PHOTOCURABLE RESIN COMPOSITION PSMC6, PCNA, POLR2B MMP2 3435/4885DBH 2447/4885HDAC4 3257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.